UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Congress Park Capital LLC

Congress Park Capital LLC trimmed its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 22.4% during the third quarter, HoldingsChannel reports. The institutional investor owned 1,050 shares of the healthcare conglomerate’s stock after selling 303 shares during the quarter. Congress Park Capital LLC’s holdings in UnitedHealth Group were worth $614,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of the business. Delta Financial Group Inc. lifted its position in UnitedHealth Group by 1.0% during the third quarter. Delta Financial Group Inc. now owns 1,650 shares of the healthcare conglomerate’s stock valued at $965,000 after buying an additional 17 shares in the last quarter. Signature Resources Capital Management LLC raised its stake in shares of UnitedHealth Group by 40.0% during the second quarter. Signature Resources Capital Management LLC now owns 63 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 18 shares during the period. Saxony Capital Management LLC raised its stake in shares of UnitedHealth Group by 3.5% during the second quarter. Saxony Capital Management LLC now owns 530 shares of the healthcare conglomerate’s stock valued at $270,000 after purchasing an additional 18 shares during the period. GoalVest Advisory LLC raised its stake in shares of UnitedHealth Group by 0.6% during the second quarter. GoalVest Advisory LLC now owns 3,124 shares of the healthcare conglomerate’s stock valued at $1,591,000 after purchasing an additional 18 shares during the period. Finally, Fiduciary Group LLC raised its stake in shares of UnitedHealth Group by 0.5% during the second quarter. Fiduciary Group LLC now owns 3,695 shares of the healthcare conglomerate’s stock valued at $1,882,000 after purchasing an additional 18 shares during the period. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on UNH shares. KeyCorp started coverage on shares of UnitedHealth Group in a research note on Friday. They set an “overweight” rating and a $675.00 price objective on the stock. UBS Group lifted their price target on shares of UnitedHealth Group from $640.00 to $680.00 and gave the stock a “buy” rating in a research note on Thursday, July 18th. Morgan Stanley lifted their price target on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research note on Wednesday, July 17th. Jefferies Financial Group upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and lifted their price target for the stock from $481.00 to $647.00 in a research note on Wednesday, July 17th. Finally, Robert W. Baird lifted their price target on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and a consensus target price of $617.37.

UnitedHealth Group Price Performance

UNH stock traded up $2.09 during trading on Friday, hitting $599.79. The company had a trading volume of 478,497 shares, compared to its average volume of 3,913,877. The firm has a market capitalization of $553.86 billion, a price-to-earnings ratio of 39.63, a P/E/G ratio of 1.65 and a beta of 0.58. The business has a 50 day moving average of $583.48 and a 200 day moving average of $530.04. UnitedHealth Group Incorporated has a fifty-two week low of $436.38 and a fifty-two week high of $607.94. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, topping the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion during the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the prior year, the company posted $6.14 earnings per share. The company’s quarterly revenue was up 6.4% compared to the same quarter last year. As a group, research analysts predict that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 24th. Shareholders of record on Monday, September 16th were given a $2.10 dividend. This represents a $8.40 annualized dividend and a yield of 1.40%. The ex-dividend date was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 55.70%.

Insiders Place Their Bets

In other UnitedHealth Group news, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction dated Wednesday, July 17th. The stock was sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the sale, the chief accounting officer now owns 29,501 shares in the company, valued at approximately $16,812,029.88. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, EVP Erin Mcsweeney sold 1,500 shares of the company’s stock in a transaction dated Thursday, July 18th. The stock was sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares in the company, valued at $4,507,748.55. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Thomas E. Roos sold 2,851 shares of the company’s stock in a transaction dated Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total value of $1,624,727.88. Following the completion of the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.